Literature DB >> 7216575

Vocational disability and rehabilitation in multiple sclerosis.

L Scheinberg, N Holland, N Larocca, P Laitin, A Bennett, H Hall.   

Abstract

Multiple sclerosis represents a significant cause of vocational disability among young and middle age adults. As a group, M.S. patients are frequently well educated, highly trained and possess intact families but have had to leave their former occupations. While many unemployed M.S. patients are willing and able to work, they are not now receiving the vocational rehabilitation services they need to reenter the work force. Physicians frequently see M.S. patients, but they do not often refer those patients for vocational rehabilitation services. Unemployment associated with multiple sclerosis is a significant social complication of the disease. While the physician cannot cure or halt the progress of the disease, he or she can assist the M.S. patient in obtaining the specialized help necessary to re-enter the job market.

Entities:  

Mesh:

Year:  1981        PMID: 7216575     DOI: 10.1097/00004356-198103000-00008

Source DB:  PubMed          Journal:  Int J Rehabil Res        ISSN: 0342-5282            Impact factor:   1.479


  3 in total

1.  Physical medicine and rehabilitation: vocational potential in multiple sclerosis.

Authors:  B E Becker
Journal:  West J Med       Date:  1986-06

2.  Factors that influence the employment status of people with multiple sclerosis: a multi-national study.

Authors:  M Messmer Uccelli; C Specchia; M A Battaglia; D M Miller
Journal:  J Neurol       Date:  2009-12       Impact factor: 4.849

3.  Spatial and temporal distribution of the prevalence of unemployment and early retirement in people with multiple sclerosis: A systematic review with meta-analysis.

Authors:  Bruno Kusznir Vitturi; Alborz Rahmani; Guglielmo Dini; Alfredo Montecucco; Nicoletta Debarbieri; Paolo Bandiera; Mario Alberto Battaglia; Tommaso Manacorda; Benedetta Persechino; Giuliana Buresti; Michela Ponzio; Matilde Inglese; Paolo Durando
Journal:  PLoS One       Date:  2022-07-28       Impact factor: 3.752

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.